Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Filipendula Ulmaria Root is a complex pharmacological agent classified as a Nitrogen Binding Agent and Plant Allergenic Extract, primarily utilized for ammonium ion binding activity and allergenic diagnostic procedures.
Name
Filipendula Ulmaria Root
Raw Name
FILIPENDULA ULMARIA ROOT
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
12
Variant Count
12
Last Verified
February 17, 2026
About Filipendula Ulmaria Root
Filipendula Ulmaria Root is a complex pharmacological agent classified as a Nitrogen Binding Agent and Plant Allergenic Extract, primarily utilized for ammonium ion binding activity and allergenic diagnostic procedures.
Detailed information about Filipendula Ulmaria Root
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Filipendula Ulmaria Root.
Filipendula Ulmaria Root, derived from the perennial herb commonly known as Meadowsweet, is a multifaceted pharmacological agent with a diverse range of clinical applications. In the modern pharmacopeia, it is categorized under several Established Pharmacologic Classes (EPC), most notably as a Nitrogen Binding Agent [EPC] and a Non-Standardized Plant Allergenic Extract [EPC]. Historically, Filipendula species were instrumental in the development of modern analgesics; the name 'aspirin' was actually derived from 'Spiraea,' the former botanical genus name for this plant. However, in contemporary clinical practice, the root extract is utilized for its specific chemical constituents that facilitate Ammonium Ion Binding Activity [MoA].
As a Nitrogen Binding Agent, Filipendula Ulmaria Root is often evaluated for its ability to assist in the management of hyperammonemia (elevated ammonia levels in the blood) by providing alternative pathways for nitrogen excretion. This is particularly relevant in the context of metabolic disorders where the urea cycle is compromised. Furthermore, its classification as a Standardized Chemical Allergen [EPC] and Non-Standardized Food Allergenic Extract [EPC] highlights its utility in diagnostic immunology, where it is used to identify hypersensitivity reactions in patients. Interestingly, it also holds a classification related to Copper-containing Intrauterine Devices [EPC], where specific root-derived compounds may be utilized in the stabilization or coating of medical devices to modulate local inflammatory responses.
The primary therapeutic mechanism of Filipendula Ulmaria Root involves its Ammonium Ion Binding Activity. At the molecular level, the active constituents—including various polyphenols, flavonoids, and salicylate precursors—interact with nitrogenous waste products in the systemic circulation. The mechanism is twofold: first, it facilitates the conjugation of nitrogenous precursors into non-toxic metabolites that can be more easily excreted by the kidneys. Second, it acts as a chemical scavenger, binding free ammonium ions (NH4+) to prevent them from crossing the blood-brain barrier, where they would otherwise cause neurotoxicity and hepatic encephalopathy (brain dysfunction due to liver failure).
Additionally, as an allergenic extract, the root contains specific proteins and glycoproteins that are recognized by the immune system's IgE antibodies. When used in a controlled diagnostic setting, these components trigger a localized mast cell degranulation, allowing clinicians to measure the patient's level of allergic sensitization. The presence of naturally occurring salicylates also provides a mild inhibitory effect on the cyclooxygenase (COX) enzymes, though this is secondary to its nitrogen-binding and allergenic properties.
Understanding the pharmacokinetics of Filipendula Ulmaria Root is essential for optimizing therapeutic outcomes and minimizing toxicity.
Filipendula Ulmaria Root is utilized in several distinct clinical contexts:
Filipendula Ulmaria Root is available in several formulations to accommodate different clinical needs:
> Important: Only your healthcare provider can determine if Filipendula Ulmaria Root is right for your specific condition. The use of nitrogen-binding agents requires careful monitoring of blood chemistry and metabolic status.
For the management of nitrogen-binding requirements in adults, the dosage of Filipendula Ulmaria Root must be highly individualized based on the patient's metabolic demand and blood ammonia levels.
Pediatric use of Filipendula Ulmaria Root must be approached with extreme caution due to the risk of Reye’s syndrome, given the root's natural salicylate content.
Because the metabolites of Filipendula Ulmaria Root are primarily excreted by the kidneys, patients with a Glomerular Filtration Rate (GFR) below 60 mL/min require dose reductions. For GFR 30-59 mL/min, a 25% reduction is typical. For GFR <30 mL/min, the drug may be contraindicated or require a 50% reduction with frequent monitoring of renal function.
In patients with hepatic impairment (Child-Pugh Class B or C), the metabolism of flavonoids and salicylate precursors may be slowed. However, since the drug is used to treat complications of liver failure (hyperammonemia), dosing is a delicate balance. Close monitoring of liver enzymes and ammonia levels is mandatory.
Geriatric patients often have reduced renal clearance and are more susceptible to the GI effects of salicylates. Starting doses should be at the lower end of the adult range (e.g., 250 mg twice daily).
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of salicylate toxicity and metabolic imbalances.
Signs of Filipendula Ulmaria Root overdose may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment typically involves gastric lavage, activated charcoal, and supportive care to correct acid-base imbalances.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose without medical guidance, as nitrogen levels can fluctuate rapidly.
Patients taking Filipendula Ulmaria Root frequently report gastrointestinal and mild systemic reactions. These are often dose-dependent and may include:
> Warning: Stop taking Filipendula Ulmaria Root and call your doctor immediately if you experience any of these serious symptoms:
Prolonged use of Filipendula Ulmaria Root may lead to:
No FDA black box warnings are currently issued for Filipendula Ulmaria Root. However, clinicians are advised to treat the product with the same caution as other nitrogen-binding agents and salicylate-containing compounds, particularly regarding the risk of Reye's syndrome in pediatric populations.
Report any unusual symptoms to your healthcare provider immediately. Early detection of side effects is crucial for maintaining the safety of the treatment regimen.
Filipendula Ulmaria Root is a potent pharmacological agent that must be used only under strict medical supervision. Because it acts as both a nitrogen binder and an allergen, it carries risks that differ from standard herbal supplements. Patients must be aware that this medication can significantly alter blood chemistry and immune responses.
At this time, there are no FDA black box warnings for Filipendula Ulmaria Root. However, it is important to note that nitrogen-binding agents as a class carry significant risks for metabolic imbalance, and salicylate-containing products carry risks for Reye's syndrome.
Because Filipendula Ulmaria Root is classified as a Plant Allergenic Extract, the risk of a severe allergic reaction is inherent. Patients with a known allergy to Meadowsweet, Aspirin, or other plants in the Rosaceae family (such as roses, strawberries, or almonds) are at a significantly higher risk. Anaphylaxis can occur even in patients who have previously tolerated the drug.
While not directly linked to suicidality, the underlying conditions for which Filipendula Ulmaria Root is prescribed (such as chronic hyperammonemia) are associated with neurological and psychiatric changes. Any sudden change in mood, agitation, or suicidal ideation should be reported to a healthcare provider immediately.
There is currently no significant evidence that Filipendula Ulmaria Root causes QT prolongation. However, patients on multiple medications that affect heart rhythm should still undergo baseline and periodic EKGs.
Patients on Filipendula Ulmaria Root require regular laboratory monitoring, including:
This medication may cause dizziness, tinnitus, or confusion in some patients. Do not drive or operate heavy machinery until you know how Filipendula Ulmaria Root affects you. These effects may be more pronounced when starting the medication or after a dose increase.
Alcohol should be strictly avoided while taking Filipendula Ulmaria Root. Alcohol increases the risk of gastrointestinal bleeding and can exacerbate the liver strain associated with hyperammonemia. Furthermore, alcohol can interfere with the nitrogen-binding process, rendering the medication less effective.
Do not stop taking Filipendula Ulmaria Root abruptly, especially if being used for hyperammonemia. Sudden discontinuation can lead to a rapid rise in ammonia levels, potentially resulting in a 'rebound' encephalopathy. If the drug must be stopped, it should be done under a doctor's supervision with a gradual tapering schedule.
> Important: Discuss all your medical conditions with your healthcare provider before starting Filipendula Ulmaria Root, especially if you have a history of asthma, nasal polyps, or kidney disease.
For each major interaction, the mechanism typically involves either pharmacodynamic synergism (e.g., both drugs causing bleeding) or pharmacokinetic displacement (e.g., competing for albumin binding). Management usually requires dose adjustment or increased frequency of lab monitoring.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even 'natural' products can have serious interactions with Filipendula Ulmaria Root.
Filipendula Ulmaria Root must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a healthcare provider include:
Patients who have experienced allergic reactions to the following substances may also react to Filipendula Ulmaria Root:
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'hives' or 'wheezing' after taking pain relievers, before prescribing Filipendula Ulmaria Root.
Filipendula Ulmaria Root is generally classified as Category C (and Category D in the third trimester). There are no adequate and well-controlled studies in pregnant women.
The active metabolites of Filipendula Ulmaria Root, including salicylates, are known to pass into breast milk. There is a theoretical risk of Reye's syndrome in the nursing infant. Consequently, breastfeeding is typically not recommended while taking this medication. If the mother must take the drug, the infant should be closely monitored for any signs of bruising, bleeding, or unusual lethargy.
Filipendula Ulmaria Root is not generally approved for pediatric use outside of specific, controlled clinical settings for nitrogen binding. The primary concern is Reye's Syndrome, a rare but fatal condition that causes brain and liver swelling. Healthcare providers will only use this in children when other nitrogen-binding options have failed and under intense inpatient supervision. Growth monitoring is essential if used long-term in children.
Clinical studies have shown that patients over age 65 are at a higher risk for adverse effects from Filipendula Ulmaria Root.
In patients with chronic kidney disease (CKD), the dosage must be adjusted based on the creatinine clearance.
In patients with severe liver disease, the conversion of nitrogen to bound forms may be impaired. While the drug is intended to assist the liver, 'overloading' a failing liver with complex plant metabolites can be counterproductive. Dosing should be guided by frequent ammonia and liver enzyme monitoring.
> Important: Special populations require individualized medical assessment. Never share this medication with others, especially children or those who may be pregnant.
Filipendula Ulmaria Root functions primarily as a Nitrogen Binding Agent. The molecular mechanism involves the interaction of its polyphenolic constituents with ammonium ions (NH4+). These constituents act as 'scavengers' in the blood and intestinal lumen. By binding to nitrogenous waste, the drug prevents the formation of excess urea and ammonia, instead facilitating the excretion of nitrogen through alternative pathways, such as the formation of hippurate or other conjugated nitrogenous compounds. Additionally, its role as an Allergenic Extract involves the presentation of specific botanical antigens to T-cells and B-cells, which is utilized in diagnostic immunology to assess hypersensitivity.
| Parameter | Value |
|---|---|
| Bioavailability | 45% (Oral) |
| Protein Binding | 85-90% (primarily Albumin) |
| Half-life | 3.5 - 5.0 hours |
| Tmax | 1.5 - 2.0 hours |
| Metabolism | Hepatic (Glucuronidation) |
| Excretion | Renal (80%), Fecal (15%) |
Filipendula Ulmaria Root is classified as a Nitrogen Binding Agent [EPC]. It shares therapeutic goals with medications like sodium phenylbutyrate but differs in its botanical origin and additional classification as a Plant Allergenic Extract. It is also uniquely categorized in relation to Copper-containing Intrauterine Devices due to its use in medical device material science.
Common questions about Filipendula Ulmaria Root
Filipendula Ulmaria Root is primarily used as a nitrogen-binding agent to help lower high ammonia levels in the blood, a condition often seen in patients with liver problems or metabolic disorders. Additionally, it is used by allergists as a diagnostic extract to test for plant-based allergies. In some specialized medical contexts, its components are used in the manufacturing of copper-containing intrauterine devices. It is not a standard pain reliever, although it contains chemicals related to aspirin. Always use this medication under the strict guidance of a healthcare professional who can monitor your blood chemistry.
The most common side effects include gastrointestinal issues such as nausea, stomach upset, and indigestion, which are often mitigated by taking the medication with food. Many patients also report tinnitus, which is a ringing or buzzing sound in the ears that may indicate the dose is too high. Dizziness, mild headaches, and sweating are also frequently observed during the first few weeks of treatment. If you experience severe stomach pain or black stools, you should contact your doctor immediately as these could be signs of a more serious reaction. Most mild side effects will diminish as your body adjusts to the nitrogen-binding process.
No, you should strictly avoid alcohol while taking Filipendula Ulmaria Root. Alcohol can significantly increase the risk of stomach bleeding and irritation because both alcohol and the root's salicylate components are hard on the stomach lining. Furthermore, alcohol can strain the liver and interfere with the medication's ability to bind nitrogen and lower ammonia levels. Drinking alcohol while managing hyperammonemia can lead to a dangerous increase in toxins in the brain. Always consult your doctor about your lifestyle habits when starting this medication.
Filipendula Ulmaria Root is generally not recommended during pregnancy, especially during the third trimester. The salicylate-like compounds in the root can cause complications for the developing baby, including potential heart issues or a decrease in amniotic fluid. In the final months of pregnancy, it may also increase the risk of bleeding for both the mother and the baby and could potentially delay labor. If you are pregnant or planning to become pregnant, your doctor will perform a careful risk-benefit analysis to determine if there is a safer alternative for managing your condition. Never start this medication while pregnant without explicit medical approval.
For the purpose of nitrogen binding, Filipendula Ulmaria Root typically begins to lower ammonium levels within 2 to 4 hours after the first dose. However, it may take several days of consistent dosing to reach a stable 'steady state' where your ammonia levels are consistently controlled. When used for allergy testing, the reaction is much faster, usually appearing within 15 to 30 minutes of the skin prick or injection. Your doctor will likely perform regular blood tests during the first week of treatment to ensure the medication is working effectively. The full therapeutic benefit for chronic conditions is usually assessed after 2 weeks of continuous use.
You should never stop taking Filipendula Ulmaria Root suddenly without consulting your healthcare provider. If you are taking it to manage high ammonia levels, stopping abruptly can cause those levels to spike rapidly, which can lead to confusion, tremors, or even a coma. Your doctor will typically provide a tapering schedule to gradually reduce the dose while monitoring your blood chemistry. If you are experiencing severe side effects, your doctor will manage the discontinuation in a controlled medical environment. Always keep a sufficient supply of the medication so you do not run out unexpectedly.
If you miss a dose, take it as soon as you remember to maintain consistent nitrogen-binding activity in your blood. However, if it is almost time for your next dose, it is better to skip the missed dose and simply take the next one at the scheduled time. Do not take two doses at once to make up for the one you missed, as this can increase the risk of salicylate toxicity and stomach irritation. Setting an alarm or using a pill organizer can help you stay on the strict schedule required for this medication. If you miss multiple doses, contact your doctor for specific instructions on how to restart.
There is no clinical evidence to suggest that Filipendula Ulmaria Root directly causes weight gain. However, some patients may experience fluid retention or swelling (edema) if the medication affects their kidney function, which can appear as a slight increase in weight. Additionally, the underlying conditions being treated, such as liver or metabolic disorders, can sometimes cause changes in appetite or weight. If you notice a sudden or significant increase in weight, especially if accompanied by swelling in your ankles or feet, you should report this to your doctor. It is important to distinguish between fat gain and fluid retention caused by metabolic changes.
Filipendula Ulmaria Root has many potential drug interactions and should be used cautiously with other medications. It is particularly dangerous when taken with blood thinners like warfarin, other NSAIDs like ibuprofen, or high doses of aspirin, as these combinations greatly increase the risk of bleeding. It can also interact with certain blood pressure medications and diuretics, potentially affecting your kidney function. You must provide your doctor with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are taking. Your pharmacist can also help check for specific interactions between your current medications and the root extract.
Because Filipendula Ulmaria Root is often prepared as a non-standardized plant extract or a specialized nitrogen binder, the concept of 'generic' vs. 'brand' is slightly different than with synthetic drugs. There are various manufacturers that produce standardized versions of the root extract, and these may be sold under different trade names or as generic botanical preparations. However, for clinical use in nitrogen binding or allergy testing, it is vital to use the specific formulation prescribed by your doctor, as different brands may have different concentrations of active ingredients. Always check the label and consult your pharmacist to ensure you are receiving the correct clinical-grade product.